Kindora
FeaturesSocial Enterprise FundingPricingFor FundersFor ConsultantsDevelopers
AboutLive Demos
Sign InSign Up
    Kindora
    FeaturesSocial Enterprise FundingPricingFor FundersFor ConsultantsDevelopers
    AboutLive Demos
    Sign InSign Up
    1. Home
    2. Foundations
    3. Bristol-Myers Squibb Patient Assistance Foundation
    Bristol-Myers Squibb Patient Assistance Foundation logo

    Bristol-Myers Squibb Patient Assistance Foundation

    ActiveHuman ServicesFunds Individuals
    PRINCETON, NJWebsite2125464200

    About Bristol-Myers Squibb Patient Assistance Foundation

    The foundation is overwhelmingly dedicated to providing direct prescription drug assistance to individual patients in need, funding a patient assistance program that covers medication costs for low-income, ill, and infant populations. Nearly all recorded giving is funneled into a single patient-focused program rather than to nonprofit intermediaries or diverse causes, indicating a mission centered on access to medicines for vulnerable individuals.

    Focus Areas

    Direct prescription drug assistance for low-income patientsPatient assistance for serious and chronic illnessesMeans-tested enrollment and financial support for medication access

    Who They Fund

    infantslow-income/needy individualspeople with qualifying illnesses (chronically ill patients)

    Giving Approach

    Extremely concentrated: virtually all funding is directed to a single patient assistance program across a very small number of grants. The foundation makes very large, program-specific disbursements focused on direct-to-patient support rather than diversified or repeat grants to multiple nonprofit organizations.

    About Bristol-Myers Squibb Patient Assistance Foundation

    Bristol-myers Squibb Patient Assistance Foundation Inc directs almost all of its giving to a single purpose: prescription drug assistance for individual patients. The recent record shows three large grants to Individual Patient Programs in Princeton, New Jersey, all labeled for prescription drugs for the care of qualified ill, needy, and infants. That pattern points to a funder built around direct medication support rather than a broad charitable portfolio. The foundation’s active program, the Patient Medicine Assistance Program, provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines. The focus is on access to medicines for people facing financial barriers, including low-income patients and individuals with qualifying illnesses. Because the foundation funds individuals, its grantmaking is structured around patient assistance rather than grants to nonprofit intermediaries. Across the latest filings, the foundation’s work is tightly centered on medication access in the United States, with every recorded grant going to a patient-focused program in Princeton.

    What Bristol-Myers Squibb Patient Assistance Foundation Funds

    The foundation’s core work is prescription drug assistance. Its active Patient Medicine Assistance Program provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines. That makes medication access, rather than general health programming, the clearest throughline in its grantmaking. Its recent grants also show support for qualified ill, needy, and infant populations through Individual Patient Programs in Princeton, New Jersey. The purpose language consistently ties funding to prescription drugs for care, which places the foundation in direct-service healthcare support. The beneficiary profile is narrow and specific: infants, low-income or needy individuals, and people with qualifying illnesses. The philosophy tags reinforce that pattern with direct service, in-kind support, targeted assistance, and healthcare access support.

    How Bristol-Myers Squibb Patient Assistance Foundation Gives

    The grant-size distribution is extremely large and tightly clustered: p25 is $3,245,667,810, the median is $3,627,470,508, and p75 is $4,009,273,205. That range suggests very high-volume, program-level support rather than many small discretionary awards. The recent record shows repeat funding to the same recipient program across 2023, 2024, and 2025, indicating ongoing support rather than one-off grants. The foundation is a regular funder and funds individuals directly. It also accepts unsolicited requests for its Patient Medicine Assistance Program.

    Financial Snapshot

    Annual Giving

    $2.7B

    Total Assets

    $230.7M

    Total Revenue

    $2.7B

    Total Expenses

    $2.7B

    Typical Grant Size

    Most grants fall between $3.2B and $4B, with a median of $3.6B.

    25th Percentile

    $3.2B

    Median

    $3.6B

    75th Percentile

    $4B

    Geographic Reach

    Local1 state funded
    Funding intensity
    Low
    High
    Headquarters

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    Explore related grant guides

    Human Services GrantsHuman Services Grants in New JerseyGrants in New Jersey

    Want a Personalized Pitch for Bristol-Myers Squibb Patient Assistance Foundation?

    Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.

    Get Started FreeView Pricing
    Free plan available
    No contracts
    Cancel anytime
    Free weekly newsletter

    The Grant Brief

    Weekly grant intelligence for social impact leaders. Curated opportunities, funding trends, and strategic insights — free.

    Join 500+ social impact leaders. Unsubscribe anytime. Privacy Policy

    Weekly grant intelligence in your inbox. No spam — unsubscribe anytime.

    Kindora Logo

    Funders you can find. Funders you can reach.

    Get The Grant Brief — free weekly grant intelligence

    Quick Links

    • Features
    • Social Enterprise Funding
    • About Us
    • Where our information comes from
    • For funders
    • For consultants
    • Writing with AI, honestly
    • Success Stories
    • Mission
    • How It Works
    • Pricing
    • Developers
    • Sales deck
    • Live Demand Wall
    • Philanthropy Jobs
    • Nonprofit Compensation
    • Invest in Kindora
    • Live demo (every plan)
    • Individual prospecting demoBeta
    • Blog
    • FAQ
    • Getting Started

    Connect With Us

    LinkedIn

    Find Grants

    Grants by CauseGrants by StateFoundations by CityEducation GrantsHealth GrantsArts & Culture GrantsEnvironment GrantsCommunity Development GrantsYouth Development Grants

    © 2026 Kindora. All rights reserved.

    Privacy PolicyTerms of ServiceYour privacy choicesEnvironmental footprintSystem Status
    EIN (Tax ID): 22-3622487Latest Form 990: 2025Total assets: $230.7M3 filings on recordFind their full 990 filing →
    See If You're a Fit — FreeFree account · instant fit score · similar funders

    Funding Style

    direct servicein-kind support (medication provision)targeted assistancehealthcare access support

    Notable grantees: INDIVIDUAL PATIENT PROGRAMS

    Topics

    prescription drug assistancemedication access programspediatric/infant pharmacological carechronic illness medication managementlow-income patient medication support

    Where Bristol-Myers Squibb Patient Assistance Foundation Makes Grants

    Grantmaking is local and entirely concentrated in the United States. All recorded grants in the recent sample went to Princeton, New Jersey, and New Jersey accounts for 100% of grants in the file. The recipient country distribution shows US: 3 grants. The pattern is therefore geographically narrow, with no recorded non-U.S. recipients.

    Frequently Asked Questions About Bristol-Myers Squibb Patient Assistance Foundation

    What does this foundation fund?

    It funds direct prescription drug assistance for individual patients. The active Patient Medicine Assistance Program provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines.

    Who receives support?

    The foundation’s grants are aimed at individual patients, including qualified ill, needy, and infant populations. The beneficiary profile also includes low-income or needy individuals and people with qualifying illnesses.

    How large are the grants?

    The grant-size distribution is very large: p25 is $3,245,667,810, the median is $3,627,470,508, and p75 is $4,009,273,205. The recent filings show repeated multibillion-dollar program support.

    Does it accept unsolicited requests?

    Yes. The active Patient Medicine Assistance Program is listed as accepting unsolicited requests, and it is focused on helping eligible patients obtain listed medicines temporarily.

    Where does the foundation give?

    Its giving is local and concentrated in the United States. In the recent grant sample, all recorded grants went to Princeton, New Jersey, and New Jersey accounts for 100% of grants in the file.

    Latest 990 Filing

    2025

    Source: IRS Form 990-PF, fiscal year 2025.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$2,658,494,8662025PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$4,391,075,9032024PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$2,863,865,1122023PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $2,658,494,866
    PRINCETON, NJ2025

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $4,391,075,903
    PRINCETON, NJ2024

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $2,863,865,112
    PRINCETON, NJ2023

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS